Investor Presentation • Oct 1, 2025
Investor Presentation
Open in ViewerOpens in native device viewer

Table of contents


Completion of renovation and upgrading of the Emergency Department, laundry areas – basements and nursing departments on the 5th floor of the central wing of the General Hospital of Attica "KAT"
Expansion of the Emergency Department and construction of a resuscitation room at the General Hospital of Ioannina, budget €3.5mn



Larger sized projects and rapid execution led to a significant increase in turnover

Public Projects 53% Private Projects 47% Backlog Breakdown1 105.686 122.981 Backlog (€ '000) 31.12.2024 30.09.2025 1. Backlog includes only signed projects. Projects to be signed are excluded. €123.0mn
3.338 7.209 Gross Profit (€ '000) 30.06.2024 30.06.2025 9,4% 17,2% Gross Margin (%) 30.06.2024 30.06.2025 +116.0% +780bp





Source: ΑΤΗΕΧ

| Statement of Financial Position | ||||
|---|---|---|---|---|
| (amounts in €) ASSETS |
GROUP 30.06.2025 |
31.12.2024 | COMPANY 30.06.2025 |
31.12.2024 |
| Own-used tangible fixed assets | 32,529,382 | 32,788,682 | 32,529,382 | 32,788,682 |
| Investment property | 7,975,500 | 7,975,500 | 7,920,500 | 7,920,500 |
| Right to use assets | 365,136 | 438,280 | 365,136 | 438,280 |
| Other intangible assets | 49,744 | 54,195 | 49,744 | 54,195 |
| Investments in joint ventures | - | - | 231,900 | 231,900 |
| Other long-term receivables | 138,290 | 139,290 | 138,290 | 139,290 |
| Deferred tax receivables Total Non-Current Assets |
62,494 41,120,545 |
58,547 41,454,494 |
62,494 41,297,445 |
58,547 41,631,394 |
| Trade receivables | 16,271,088 | 26,911,421 | 16,271,088 | 26,911,421 |
| Receivables from contractual assets | 9,469,472 | 3,838,607 | 9,469,472 | 3,838,607 |
| Other receivables | 8,701,325 | 9,233,950 | 8,577,379 | 9,241,536 |
| Cash & cash equivalents | 14,721,867 | 10,174,615 | 14,704,074 | 10,166,896 |
| Total Current Assets | 49,163,752 | 50,158,593 | 49,022,013 | 50,131,460 |
| Total Assets | 90,284,298 | 91,613,087 | 90,319,459 | 91,762,854 |
| EQUITY | ||||
| Share capital | 6,988,457 | 6,988,457 | 6,988,457 | 6,988,457 |
| Premium Other reserves |
12,476,805 4,866,130 |
12,476,805 4,854,560 |
12,476,805 4,845,994 |
12,476,805 4,845,994 |
| Retained earnings/losses | 24,271,056 | 19,760,047 | 24,168,549 | 19,758,120 |
| Total Equity | 48,602,449 | 44,079,869 | 48,479,806 | 44,069,377 |
| LIABILITIES | ||||
| Long-term loans | 12,144,444 | 12,466,667 | 12,144,444 | 12,466,667 |
| Long-term financial lease liability | 148,474 | 230,723 | 148,474 | 230,723 |
| Deferred tax liability | 3,379,139 | 2,200,800 | 3,440,664 | 2,261,488 |
| Other long-term liabilities | 1,245,819 | 1,312,873 | 1,245,819 | 1,312,873 |
| Provisions for post-employment benefits for employees | 40,425 | 40,425 | 40,425 | 40,425 |
| Total Long-Term Liabilities | 16,958,301 | 16,251,487 | 17,019,826 | 16,312,175 |
| 9,883,060 | 12,855,518 | 9,879,340 | 12,855,090 | |
| Suppliers and other liabilities | 7,256,257 1,420,855 |
8,829,257 | 7,256,257 | 8,829,257 |
| Contractual obligations | 2,210,477 | 1,420,855 | 2,210,477 | |
| Loans | 240,613 | 242,966 | 240,613 | |
| Short-term financial lease liability | 242,966 | |||
| Liabilities from taxes - duties |
3,390,108 | 4,997,933 | 3,390,108 | 4,997,933 |
| Other liabilities | 2,530,301 | 2,147,934 | 2,630,301 | 2,247,933 |
| Total Short-Term Liabilities Total Liabilities |
24,723,548 41,681,849 |
31,281,731 47,533,218 |
24,819,827 41,839,653 |
31,381,302 47,693,477 |
| Statement οf Comprehensive Income | |||||
|---|---|---|---|---|---|
| GROUP | COMPANY | ||||
| (amounts in €) |
01.01 - 30.06.2025 |
01.01 - 30.06.2024 |
01.01 - 30.06.2025 |
01.01 - 30.06.2024 |
|
| Turnover | 41,862,741 | 35,444,579 | 41,862,741 | 34,441,689 | |
| Cost of sales | (34,653,717) | (32,106,607) | (34,653,717) | (30,263,661) | |
| Gross Margin | 7,209,023 | 3,337,973 | 7,209,023 | 4,178,028 | |
| Other income | 526,900 | 142,396 | 400,295 | 75,596 | |
| Administrative expenses | (1,206,398) | (1,475,060) | (1,202,887) | (1,456,760) | |
| Other expenses | (104,835) | (273,945) | (81,536) | (271,156) | |
| Income from participations and investments | (6,219) | 4,323,823 | (6,219) | (16,110) | |
| Earnings Before Interest & Taxes | 6,418,471 | 6,055,187 | 6,318,677 | 2,509,599 | |
| Interest income | 803,051 | 198,921 | 803,051 | 198,921 | |
| Interest expanse | (1,220,488) | (484,930) | (1,220,438) | (214,885) | |
| Earnings Before Taxes | 6,001,033 | 5,769,178 | 5,901,289 | 2,493,635 | |
| Income tax | (1,490,024) | (574,162) | (1,490,860) | (615,926) | |
| Profit for the Period After Taxes | 4,511,009 | 5,195,015 | 4,410,429 | 1,877,709 | |
| EBITDA | 7,059,803 | 2,777,136 | 6,960,008 | 2,704,379 | |
Source: Semiannual Financial Report
| Statement of Cash Flows | ||||
|---|---|---|---|---|
| GROUP | COMPANY | |||
| (amounts in €) | 01.01 - 30.06.2025 |
01.01 - 30.06.2024 |
01.01 - 30.06.2025 |
01.01 - 30.06.2024 |
| Cash Flows from Operating Activities | ||||
| Profit (loss) Before Taxes | 6.001.033 | 5.769.177 | 5.901.289 | 2.493.635 |
| Adjustments for: | ||||
| Results from investment activity | - | (4.339.933) | - | - |
| Changes in liabilities due to staff retirement | - | 504.003 | - | 73.095 |
| Depreciation of tangible fixed assets | 509.730 | 4.384 | 509.730 | 2.551 |
| Amortization of intangible assets | 4.451 | 103.025 | 4.451 | 103.025 |
| Amortization of rights of use | 120.931 | - | 120.931 | - |
| Impairment of doubtful receivables | - | 103.158 | - | 103.158 |
| Losses from construction contracts | (294.914) | 16.110 | (294.914) | 16.110 |
| Share of net gains (losses) from associates, accounted for using the equity-method | 6.219 | (198.921) | 6.219 | (198.921) |
| Interest collected | (803.051) | 484.931 | (803.051) | 214.885 |
| Interest paid | 1.220.488,25 | - | 1.220.438 | - |
| Total adjustments | 763.856 | (3.323.243) | 763.805 | 313.902 |
| Changes in working capital | ||||
| (Increase) / Decrease in customer and other receivables | 5.215.882 | (6.994.669) | 5.320.414 | (6.924.538) |
| Increase / (Decrease) in suppliers and other liabilities | (5.527.123) | 5.418.953 | (5.541.985) | 3.071.601 |
| Net Cash Flows from Operating Activities | 6.453.647 | 870.217 | 6.443.523 | (1.045.400) |
| Cash Flows from Investing Activities | ||||
| Purchases of tangible fixed assets | (250.431) | (542.745) | (250.431) | (511.769) |
| Purchases of intangible assets | - | (6.210) | - | (6.210) |
| Purchases of investment property | - | (66.710) | - | (66.710) |
| Acquisition/sale of subsidiaries, joint ventures and other investments | 1.000 | 747.461 | 1.000 | 645.000 |
| Net Cash Flows from Investing Activities | (249.431) | 131.796 | (249.431) | 60.311 |
| Cash Flows from Financing Activities | ||||
| Repayment of loans | (1.111.845) | (544.032) | (1.111.845) | (226.626) |
| Payment of financial lease liabilities | (127.682) | (98.940) | (127.682) | (98.940) |
| Dividends paid to shareholders of the company | - | (1.818.385) | - | (1.818.385) |
| Interest paid | (1.220.488) | (484.931) | (1.220.438) | (214.885) |
| Interest collected | 803.051 | 198.921 | 803.051 | 198.921 |
| Net Cash Flows from Financing Activities | (1.656.964) | (2.747.366) | (1.656.914) | (2.159.915) |
| Net Increase / (Decrease) in Cash & Cash Equivalents | 4.547.252 | (1.745.353) | 4.537.178 | (3.145.003) |
| Cash and cash equivalents at the beginning of the period Cash & Cash Equivalents at the End of the Period |
10.174.615 14.721.867 |
15.165.135 13.419.782 |
10.166.896 14.704.074 |
15.151.818 12.006.815 |
Source: Semiannual Financial Report
| EKTER S.A. | ||
|---|---|---|
| BACKLOG | ||
| (in € '000) 26,509 |
||
| 100% | 11,355 | |
| 11,061 | ||
| 100% | 10,349 | |
| 8,175 | ||
| 100% | 8,087 | |
| 100% | 7,937 | |
| 7,722 | ||
| 6,473 | ||
| 100% | 4,266 | |
| 3,212 | ||
| 50% | 3,192 | |
| 100% | 2,677 | |
| 100% | 2,362 | |
| 100% | 2,361 | |
| 1,975 | ||
| 1,652 | ||
| 1,271 2,345 |
||
| (%) PARTICIPATION 100% BUILDING INFRASTRUCTURE OF THE INSTITUTE OF MEDITERRANEAN STUDIES OF TRI (RETHYMNO)" (SUBPROJECT 5) OF THE 50% 50% CONSTRUCTION OF A BUILDING DEDICATED TO CELL AND GENE THERAPIES AND HEMATOLOGY CLINIC LABORATORIES AT THE 100% 50% EXPANSION OF THE INTENSIVE CARE UNIT AND CONSTRUCTION OF A RESUSCITATION ROOM AT THE GENERAL HOSPITAL OF 100% "INFRASTRUCTURE OF RESEARCH & INNOVATION OF TRI (IOANNINA)" (SUBPROJECT 10) OF THE PROJECT "1. TECHNOLOGY AND EXPANSION OF THE BUILDING FACILITIES OF THE INSTITUTE OF INFORMATICS AND TELECOMMUNICATIONS (I.P&T) OF NSR "D" "INNOVATIVE INSTALLATION OF GREEN ENERGY TRANSITION (PATRA)" (SUBPROJECT 9) OF THE PROJECT "1. TECHNOLOGY AND 100% STAVROS NIARCHOS FOUNDATION (SNF) BUILDING COMPLEX, "FOTIS KONTOUGLOU" SCHOOL OF HAGIOGRAPHY & BYZANTINE 100% |
21
Kostantinos Sipsas Bouzas Chief Executive Officer
Investor Relations Officer
Nikis 15, Athens, 10557 Τηλ.: 210 3259700 | e-mail: [email protected] www.ekter.gr
This presentation may contain forward-looking statements, which are based on estimates and assumptions about expected developments and other factors that affect the company. These estimates are not historical facts and do not constitute a guarantee for the future performance of the company. These forward-looking statements involve risks and uncertainties as there are factors that may cause the company's future results to significantly deviate from these estimates. More information on potential risks and uncertainties affecting EKTER S.A. is described in the fillings made by EKTER S.A. in ATHEX. Forward looking statements refer only to the date of this presentation. This presentation is a product of EKTER S.A. Copying, distribution and use without the company's permission is strictly prohibited.
23
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.